title: Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.
abstract: Gastroparesis is a syndrome characterized by delayed gastric emptying with associated symptoms. Gastric emptying is a complex process and pyloric dysfunction may play a key role in select subsets of patients with gastroparesis. Diagnostic tests to measure pyloric physiology are now available and have the potential to be more widely used in clinical practice. Targeted therapies including botulinum toxin, transpyloric stent placement, surgical pyloroplasty and endoscopic pyloromyotomy have been developed. Data are emerging regarding efficacy and durability, but these therapies may play a prominent role in select patients with gastroparesis and pyloric dysfunction.
authors: Division of Gastroenterology & Hepatology, Johns Hopkins University, 1830 East Monument Street, Room 425, Baltimore, MD 21205, USA.
authors: John O
authors: JO
authors: Clarke
authors: Neurogastroenterology and Motility, California Pacific Medical Center, 2340 Clay Street, Room 210, San Francisco, CA 94115, USA. Electronic address: snapew@sutterhealth.org.
authors: William J
authors: WJ
authors: Snape
mesh_terms: D001905:Botulinum Toxins / Q000627:therapeutic use*; D018589:Gastroparesis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011708:Pylorus / Q000503:physiopathology / Q000601:surgery*; D015607:Stents; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D001905:Botulinum Toxins
keywords: Botulinum toxin; Gastroparesis; Impedance planimetry; Pyloric stent; Pyloromyotomy; Pyloroplasty